Seres therapeutics announces the appointment of marella thorell as chief financial officer and the retirement of david arkowitz

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb), a leading microbiome therapeutics company, announced today that marella thorell will join as executive vice president and chief financial officer (cfo), as of march 25th, following david arkowitz's retirement. mr. arkowitz has served as cfo since june 2021 and will be available to assist in the transition. ms. thorell is a seasoned enterprise leader with deep life sciences and biotechnology industry experience in both p.
MCRB Ratings Summary
MCRB Quant Ranking